
Physician-reviewed hormone education
Gonadorelin can stimulate the pituitary to release LH and FSH—but its clinical usefulness depends heavily on diagnosis, dosing pattern and delivery method. It should not be treated as a simple one-for-one substitute for hCG.
Medically reviewed by Dr. Timothy Mackey
Medical Director · Updated September 2026

Yes, gonadorelin works pharmacologically—but that does not mean it works like hCG when used on a typical TRT schedule. Gonadorelin is a form of gonadotropin-releasing hormone, or GnRH. It acts at the pituitary and can trigger release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) when the pituitary is capable of responding.
The important distinction is that normal GnRH physiology is pulsatile. In men with certain forms of hypogonadotropic hypogonadism, medically supervised pulsatile GnRH therapy can restore gonadotropin secretion and support testosterone production and spermatogenesis. That is very different from assuming that a few intermittent gonadorelin injections each week will reliably reproduce the effect of hCG in a man taking exogenous testosterone.
Gonadorelin is synthetic GnRH, the hormone normally released by the hypothalamus. GnRH travels to the pituitary gland and stimulates release of LH and FSH. LH acts primarily on Leydig cells in the testes to support testosterone production, while FSH contributes to spermatogenesis through Sertoli-cell signaling.
That upstream mechanism is fundamentally different from hCG. hCG acts more directly at the testis by binding the LH receptor. Gonadorelin depends on an intact, responsive pituitary and physiologic stimulation of that gland.
GnRH is normally secreted in pulses rather than continuously. That pulsatility is essential to normal hypothalamic-pituitary-gonadal signaling. Continuous exposure can desensitize pituitary GnRH receptors, while appropriately timed pulsatile exposure can stimulate LH and FSH secretion.
This is why successful clinical use of gonadorelin in men with congenital or acquired hypogonadotropic hypogonadism has historically involved pulsatile administration—often with an infusion pump delivering small doses repeatedly over the day—not simply one or two injections per week.
That question needs context. Gonadorelin and hCG act at different levels of the reproductive axis and should not be considered interchangeable medications.
For selected men with hypogonadotropic hypogonadism and a functioning pituitary, pulsatile GnRH can be highly effective. For fertility treatment, professional guidelines also recognize gonadotropin therapy such as hCG, with FSH added when needed, as an established approach. The AUA/ASRM male infertility guideline specifically notes that men with hypogonadotropic hypogonadism may achieve spermatogenesis and pregnancies with either exogenous gonadotropins or pulsatile GnRH.
For men on routine TRT, however, evidence does not support assuming that intermittent gonadorelin injections given on an hCG-like schedule will provide equivalent preservation of intratesticular testosterone, testicular volume or spermatogenesis.
Exogenous testosterone therapy suppresses hypothalamic GnRH as well as pituitary LH and FSH through negative feedback. This suppression can reduce intratesticular testosterone and sperm production.
The 2024 AUA/ASRM guideline advises against prescribing exogenous testosterone to men interested in current or future fertility. Adding gonadorelin or hCG should not be assumed to remove that concern. A reproductive specialist can evaluate alternatives and monitor semen parameters.
Men concerned about fertility should review our TRT and fertility guide.
There is not enough evidence to say that a standard intermittent gonadorelin injection protocol reliably preserves fertility in men receiving exogenous testosterone. Much of the positive literature on gonadorelin involves men with hypogonadotropic hypogonadism receiving true pulsatile therapy, which is a different clinical situation.
If fertility is important, the correct evaluation should include reproductive history, semen analysis and hormone testing when appropriate—not simply whether testicular size appears unchanged. See Will Your Testicles Shrink on TRT? for more about testicular changes during treatment.
hCG is an LH analogue that acts directly on Leydig cells and can increase intratesticular testosterone. It has a different pharmacologic profile from gonadorelin and does not require the same pulsatile pituitary stimulation.
In male infertility care, AUA/ASRM guidance allows clinicians to use hCG, SERMs or aromatase inhibitors in selected infertile men with low testosterone, depending on the clinical setting. For hypogonadotropic hypogonadism, hCG is commonly used first, with FSH or an FSH analogue added when necessary to optimize sperm production.
Read more about hCG therapy and enclomiphene for men. Our guide to hCG for men on TRT covers fertility, testicular function and safety; hCG vs. Clomid explains how those approaches differ.
Pulsatile GnRH therapy is most relevant when the hypothalamus is not providing appropriate GnRH stimulation but the pituitary and testes retain the ability to respond. This can occur in selected men with congenital or acquired hypogonadotropic hypogonadism.
It is generally not expected to correct primary testicular failure, because the problem in that setting is at the testes rather than the hypothalamus. It may also be ineffective when pituitary function is significantly impaired.
A semen analysis is the most direct way to evaluate sperm concentration and other semen parameters. Bloodwork may include morning testosterone, LH, FSH, estradiol and prolactin depending on the clinical situation. Men with abnormal semen parameters or suspected male infertility may benefit from evaluation by a reproductive urologist or male fertility specialist.
Serum testosterone alone cannot tell a man whether he is fertile.
No. Gonadorelin is GnRH and acts at the pituitary. hCG acts primarily at LH receptors in the testes. Their mechanisms, pharmacology and dosing strategies are different.
It can stimulate LH and FSH release when the pituitary is responsive. Whether that translates into a clinically meaningful testosterone increase depends on the diagnosis and delivery method.
Because physiologic GnRH signaling is pulsatile. Repeated small pulses can stimulate the pituitary in a way that occasional injections may not reproduce.
There is not strong evidence that intermittent gonadorelin given on a typical TRT schedule is an equivalent substitute for hCG for this purpose. Treatment should be selected according to the actual goal—fertility, endogenous testosterone production, symptom management or another clinical indication.
Discuss the goal early. A semen analysis and individualized fertility evaluation are more useful than waiting until conception becomes difficult. Exogenous testosterone can suppress sperm production, and adding another hormone does not guarantee fertility.
NovaGenix can review your current hormone protocol, laboratory results and fertility goals and help determine what questions should be addressed before changing therapy. Learn more about Dr. Timothy Mackey and NovaGenix Health & Wellness.
Call 561-277-8260 | Text NovaGenix | Schedule a Consultation
This article is educational and does not replace individualized medical care. Hormone and fertility medications should be prescribed and monitored by an appropriately licensed clinician.
Speak with NovaGenix about physician-led evaluation, testing, and treatment options in Jupiter, Florida.
Medical disclaimer: This article is for general educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Reading it does not create a physician-patient relationship. Always consult a qualified healthcare professional about your individual circumstances, and never delay seeking care because of something you read here. If you are experiencing a medical emergency, call 911. Read our full Medical Disclaimer.


609 N Hepburn avenue suite 106. Jupiter, Florida 33458
609 N Hepburn avenue suite 106. Jupiter, Florida 33458
561-277-8260
Learn what you want to know about hormone therapy by scheduling a free consultation.
Contact Us Today609 N Hepburn Ave Ste 106, Jupiter, FL 33458
Monday - Friday: 9:00 am - 5:00 pm | Saturday-Sunday: Closed